SCHEMBL2343964

SCHEMBL2343964

O=[N+]([O-])c1cccc(-n2c(N3CCNCC3)cc3ccccc32)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 2/20 0.49
▸ HTR1A P08908 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ADRB1 P08588 1/20 0.46
▸ SIRT6 Q8N6T7 1/20 0.46
▸ HTR3E A5X5Y0 1/20 0.43
▸ HTR3B O95264 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ SLC6A4 P31645 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ THPO P40225 1/20 0.43
▸ HTR3A P46098 1/20 0.43
▸ HTR3D Q70Z44 1/20 0.43
▸ HTR3C Q8WXA8 1/20 0.43
▸ FGFR1 P11362 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11555106 0.81 HTR3E (0.53) HTR7HTR1AKDM4EADRB1HTR3E
SCHEMBL519878 0.79 HTR1A (0.72) HTR7HTR1AKDM4EMEN1MAPT
SCHEMBL2345155 0.79 HTR1A (0.44) HTR7HTR1AADRB1HTR3EHTR3B
SCHEMBL2346242 0.79 ADRB1 (0.60) HTR7HTR1AADRB1HTR3EHTR3B
Hydrochloric Acid SCHEMBL1364478 0.78 HTR1A (0.70) HTR7HTR1AKDM4EMEN1MAPT
SCHEMBL2348220 0.77 ADRB1 (0.62) HTR7HTR1AADRB1HTR3EHTR3B
SCHEMBL2348204 0.75 PDE4A (0.45) HTR7HTR1AKDM4EMEN1MAPT
SCHEMBL30417472 0.75 PDE4A (0.45) HTR7HTR1AKDM4EMEN1MAPT
SCHEMBL2232414 0.75 HTR1A (0.65) HTR7HTR1AKDM4EMEN1MAPT
SCHEMBL27906471 0.74 HTR1A (0.60) HTR7HTR1AKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8008491-B2 poly(adenosine 5'-diphosphate ribose) polymerase inhibitors such as 1-phenyl-2-(piperazin-1-yl)-1,3-dihydropyrrolo[2,3-b]pyridine-3-carboxaldehyde, used in the treatment and/or prevention central nervous system and cardiovascular disorders AVENTIS PHARMACEUTICALS, INC. (US) 2011-08-30 — — US disclosed
Send feedback